Lipid disturbance and changes in adipokines, such as adiponectin, fibroblast growth factor 21 and adipocyte fatty acid-binding protein (A-FABP), also link NAFLD with CVDs [42–44]. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.